Shenzhen Hepalink Pharmaceutical Group (002399.SZ) Earnings Analysis
Shenzhen Hepalink Pharmaceutical Group (002399.SZ) next reports earnings on 2026-08-29, consensus EPS 0.08 CNY. Last quarter (2026-04-29) it beat with EPS 0.1278 CNY vs 0.11 CNY est (+16.2%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 37.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002399.SZ next report earnings?
| Next earnings date | 2026-08-29 |
|---|---|
| Consensus EPS estimate | 0.08 CNY |
| Revenue estimate | 1.40B |
002399.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | 0.1278 CNY | 0.11 CNY | +16.2% | Beat |
| 2026-03-29 | -0.14 CNY | -0.15 CNY | +6.7% | Beat |
| 2025-10-30 | 0.08977 CNY | 0.09 CNY | -0.3% | Miss |
| 2024-10-30 | 0.07935 CNY | 0.07 CNY | +13.4% | Beat |
| 2024-08-30 | 0.3467 CNY | 0.31 CNY | +11.8% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
002399.SZ valuation and analyst view
| Trailing P/E | 37.14 |
|---|---|
| Trailing EPS | 0.25923 CNY |
| Price / book | 1.16 |
| Dividend yield | 1.50% |
| Market cap | 12.01B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shenzhen Hepalink Pharmaceutical Group (002399.SZ)'s next earnings date?
Shenzhen Hepalink Pharmaceutical Group is next scheduled to report on 2026-08-29, with a consensus EPS estimate of 0.08 CNY and revenue estimate of 1.40B.
Did 002399.SZ beat earnings last quarter?
In its 2026-04-29 report, 002399.SZ posted EPS of 0.1278 CNY versus a 0.11 CNY estimate — a beat of 16.2%.
What is 002399.SZ's earnings track record?
Over the last 5 reported quarters with consensus data, 002399.SZ beat estimates 4 times (80%).
What is 002399.SZ's current P/E ratio and EPS?
002399.SZ trades at a trailing P/E of 37.14 on trailing EPS of 0.2592274551528606 CNY.
What do analysts rate 002399.SZ?
002399.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.